U.S. health panel finds more harm than good in PSA screening
Contrary to scientists' views, MD Anderson drug discovery institute is "not a research program"
CPRIT comments on Alfred Gilman's plans to leave
Al Gilman cites concerns about peer review in resignation letter
A 25-year-old research associate may have contracted fatal meningococcal infection in the lab
Agency to fund $20 million in grants for exploring uses for 24 compounds
Plan seeks to involve institutions in identifying studies that could be used for both good and harm
Database will hold gusher of data from NCI's tumor sequencing projects
U.S. Senate hearing examines "dual-use" biological research
April 27, 2012 12:24 PM
|
by
Martin Enserink
Researcher gets license to “export” revised manuscript
U.S. Senate hearing explores H5N1 debate
Scientists discuss how NIH should recruit 100,000 mothers and kids
by
Martin Enserink
Fouchier and colleagues agree to apply for export license—under protest
Judges ask whether they must defer to their own court's previous ruling
Representative Sensenbrenner writes letter to NIH director
Senate also plans hearing on dual use research for 26 April
Texas signed off on what's said to be the first state-level oversight on experimental adult stem cells treatments.
Meeting next week will discuss a range of options
April 16, 2012 10:42 AM
|
by
Jon Cohen
Research shows how to make H5N1 virus transmissible in mammals
by
Jon Cohen
Member of U.S. advisory board assails meeting that led to recommendation to publish
Scientific society clarifies that it has not taken a position
Risks of linking an individual to public research data are low, agency says
Potential boon for clinicians also raises concerns about overuse
NIH's third-largest institute gets first permanent director in more than 2 years
President highlights tiny NIH program in attacking Romney
Government advisory body recommends full publication of both H5N1 studies
by
Angela Saini
More than 40 groups are interested in samples and data from half a million people
New policy requires federal agencies to weigh risks of studies involving 15 agents and toxins
Institute of Medicine faults Duke University's "failure" to catch problems
Report calls for DNA banks to help share worrying findings with donors
by
Michael Balter
Renewed funding for microbiome projects still under discussion
Appropriations panel questions proposed budget, aims of new center
Decision backs Mayo Clinic in fight with California company
Panelists concerned about major change in sampling strategy
For the first time in 5 years, the Howard Hughes Medical Institute is holding a general competition for a new round of up to 30 HHMI investigators. The winners...
by
Lisa Raffensperger
Following a high-pressure campaign from animal rights activists, the final ferry company that carried research animals between the United Kingdom and Europe has stopped the service, academic funders announced...
The main U.S. professional society representing gene therapists argued this week that clinical trials in their maturing field should no longer be required to undergo review by a special...
by
Jon Cohen
Officials at the U.S. Centers for Disease Control and Prevention (CDC) were bewildered when Richard Horton, editor of The Lancet, on 11 February published criticisms of the institution's Center...
by
Jon Cohen
Four papers published today in the online, open access journal mBio offer wide-ranging perspectives about the biocontainment facilities that researchers should use to work with bird flu viruses that...
It was only a matter of time, it appears. After months of silence from members of Congress, a senior member of the U.S. House of Representatives has publicly inserted...